SCHEMBL32686879

SCHEMBL32686879

CN1CCCC(CC2c3ccccc3C(=O)N2Cc2ccc3c(c2)oc(=O)n3COCC[Si](C)(C)C)C1=O

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32
▸ TNIK Q9UKE5 1/20 0.32
▸ HPGD P15428 1/20 0.31
▸ ASAH1 Q13510 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ MIF P14174 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686865 0.88 ALDH1A1 (0.35) ALDH1A1CYP1A2POLBCYP3A4CYP2D6
SCHEMBL32686803 0.85 SIGMAR1 (0.35) ALDH1A1CYP1A2POLBCYP3A4CYP2D6
SCHEMBL32686732 0.84 NPC1 (0.37) ALDH1A1CYP1A2POLBCYP3A4CYP2D6
SCHEMBL32686785 0.80 MIF (0.35) ALDH1A1CYP1A2POLBCYP3A4CYP2D6
SCHEMBL32686912 0.80 TNIK (0.36) CYP1A2POLBCYP3A4CYP2D6CYP2C9
SCHEMBL32686755 0.80 NPC1 (0.34) ALDH1A1CYP1A2POLBCYP3A4CYP2D6
SCHEMBL32686881 0.79 NPC1 (0.33) CYP1A2POLBCYP3A4CYP2D6CYP2C9
SCHEMBL32686854 0.79 TNIK (0.33) ALDH1A1CYP1A2POLBCYP3A4CYP2C9
SCHEMBL32686821 0.79 NPC1 (0.46) ALDH1A1CYP1A2POLBCYP3A4CYP2D6
SCHEMBL32686741 0.77 SIGMAR1 (0.33) SIGMAR1TNIK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 ALDH1A1 2719/4885CYP1A2 1868/4885POLB 1690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback